在毛囊淋巴瘤中,STAT6突变补偿CREBBP突变,并过度激活IL4/STAT6/RRAGD/mTOR信号传递
Qiangqiang Shao1, Karan Bedi2, Isabella A Malek1
1Departments of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA.
Leukemia
|February 5, 2025
概括
在卵泡淋巴瘤 (FL) 中激活STAT6突变可以增强IL4反应. 然而,FL中野生型STAT6的基因表达减少,与影响IL4信号和mTOR激活的CREBBP突变有关.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 信号转换器和转录激活器6 (STAT6) 的激活突变在毛囊淋巴瘤 (FL) 和其他B细胞恶性瘤中很普遍.
- 需要进一步阐明STAT6在B细胞淋巴瘤发病过程中的作用,特别是响应Interleukin-4 (IL4) 信号传递,需要进一步阐明.
研究的目的:
- 调查STAT6突变对FL中IL4诱导基因表达的影响.
- 为了确定背后的机制减弱IL4/JAK/STAT6信号在FL与野生类型的STAT6.6在FL.
- 探索STAT6,CREBBP突变和淋巴瘤中mTOR通路激活之间的联系.
主要方法:
- 在IL4刺激前后,RNA测序 (RNA-seq) 用于分析正常B淋巴细胞 (NBC) 和FL细胞 (野生型和突变STAT6) 中的基因表达.
- 实验验证CREBBP在IL4诱导的基因表达中的作用.
- 评估RRAGD表达及其在mTOR激活和B细胞受体 (BCR) 信号传递中的作用.
主要成果:
- STAT6突变大大增加了IL4诱导的基因表达.
- 与具有STAT6突变的NBC或FL相比,野生类型STAT6的FL表现出基线和IL4诱导的基因表达减少.
- 同时存在的CREBBP突变会减弱IL4/JAK/STAT6反应,因为完整的CREBBP对许多IL4诱导基因至关重要.
- IL4诱导RRAGD表达,这是mTOR激活淋巴瘤细胞所需的.
- IL4和BCR信号激活mTOR,这是一个由CREBBP和STAT6突变调节的过程.
结论:
- 在FL中,STAT6突变增强了IL4驱动的基因表达.
- CREBBP突变会损害IL4信号传递,并导致FL中野生型STAT6.6的基因表达减少.
- 在淋巴瘤中通过IL4和BCR信号传递建立了STAT6突变和mTOR调节的促生长途径之间的联系.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
T Cell Types and Functions
939
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
939


